BPA Statement June, 2005

Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.

Mark Ey, RPh, details the patient-focused factors of the ACCESS to Pharmacy Care Program and the ways in which valued care translates to reimbursement.

A new option for adults who have experienced stroke will now be available to further reduce future risk.

Investigators believe triglyceride testing could improve viral sepsis risk more broadly based on study findings.

Nicholas Rebold, PharmD, MPH, BCIDP, AAHIVP, explains how education eases inpatient switches, and how the protocol cuts costs and simplifies workflow.

Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.

Gilead’s current lenacapavir patent is what makes Dr Reddy’s Laboratories’ formulation tentative.

Mark Ey, RPh, from NCPA, joins to discuss the opportunities for independent pharmacies within the ACCESS to Pharmacy Care Program.